Published in Virology on September 01, 1968
Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52
Selection and preliminary characterization of temperature-sensitive mutants of type 5 adenovirus. J Virol (1972) 4.96
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Early events of virus-cell interaction in an adenovirus system. J Virol (1969) 3.68
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02
Purification of specific adenovirus 2 RNAs by preparative hybridization and selective thermal elution. Nucleic Acids Res (1979) 2.78
Intermediates in adenovirus assembly. J Virol (1976) 2.26
Genome structure of incomplete particles of adenovirus. J Virol (1976) 2.13
Conditional lethal mutants of adenovirus 2-simian virus 40 hybrids. I. Host range mutants of Ad2+ND1. J Virol (1974) 2.08
Nuclear matrix of HeLa S3 cells. Polypeptide composition during adenovirus infection and in phases of the cell cycle. J Cell Biol (1977) 2.04
Assembly of adenoviruses. J Virol (1973) 2.02
Structural proteins of adenovirus-associated virus type 3. J Virol (1971) 2.01
Mechanism of the arginine requirement for adenovirus synthesis. I. Synthesis of structural proteins. J Virol (1971) 1.84
Chromatin-like organization of the adenovirus chromosome. Proc Natl Acad Sci U S A (1976) 1.79
Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. EMBO J (1989) 1.77
Synthesis and processing of the precursor to the major core protein of adenovirus type 2. J Virol (1977) 1.76
Hexavalent capsomers of herpes simplex virus type 2: symmetry, shape, dimensions, and oligomeric status. J Virol (1986) 1.72
Intracellular forms of adenovirus deoxyribonucleic acid. I. Evidence for a deoxyribonucleic acid-protein complex in baby hamster kidney cells infected with adenovirus type 12. J Virol (1972) 1.68
Structural roles of polyoma virus proteins. J Virol (1972) 1.67
Synthesis, transport, and morphogenesis of type adenovirus capsid proteins. J Virol (1970) 1.67
Three size-classes of intracellular adenovirus deoxyribonucleic acid. J Virol (1971) 1.65
Synthesis of type 2 adenovirus DNA in the presence of cycloheximide. J Virol (1973) 1.62
Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J (1987) 1.56
Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J Virol (1998) 1.54
Adenovirus 3 fiber polypeptide gene: implications for the structure of the fiber protein. J Virol (1985) 1.47
Interaction of the adenovirus IVa2 protein with viral packaging sequences. J Virol (2000) 1.39
In vitro synthesis of adenovirus core proteins. J Virol (1974) 1.35
Ion etching of human adenovirus 2: structure of the core. J Virol (1984) 1.32
Characterization of type 5 adenovirus fiber protein. J Virol (1975) 1.31
Characterization of a temperature-sensitive fiber mutant of type 5 adenovirus and effect of the mutation on virion assembly. J Virol (1982) 1.31
The complete DNA sequence and genomic organization of the avian adenovirus CELO. J Virol (1996) 1.30
Role for the adenovirus IVa2 protein in packaging of viral DNA. J Virol (2001) 1.28
Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals. AAPS J (2006) 1.26
Synthesis in vitro of type 5 adenovirus capsid proteins. J Virol (1972) 1.23
Assembly intermediates among adenovirus type 5 temperature-sensitive mutants. J Virol (1978) 1.20
Characterization of a temperature-sensitive, hexon transport mutant of type 5 adenovirus. J Virol (1976) 1.17
Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner. J Virol (2004) 1.15
Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. J Virol (1999) 1.15
Chromatin structure of adenovirus DNA throughout infection. Nucleic Acids Res (2011) 1.11
Temperature-sensitive mutants of adenovirus type 12 defective in viral DNA synthesis. J Virol (1974) 1.08
Isolation and characterization of an extremely basic protein from adenovirus type 5. J Virol (1976) 1.05
Biochemical studies on bovine adenovirus type 3. I. Purification and properties. J Virol (1975) 1.03
Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J Virol (2005) 1.01
Hexon peptides of type 2, 3, and 5 adenoviruses and their relationship to hexon structure. J Virol (1975) 0.99
Adenovirus protein VII condenses DNA, represses transcription, and associates with transcriptional activator E1A. J Virol (2004) 0.98
Characterization of Empty adenovirus particles assembled in the absence of a functional adenovirus IVa2 protein. J Virol (2011) 0.96
DNA genome size affects the stability of the adenovirus virion. J Virol (2008) 0.96
Replication-attenuated Human Adenoviral Type 4 vectors elicit capsid dependent enhanced innate immune responses that are partially dependent upon interactions with the complement system. Virology (2008) 0.94
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest (1997) 0.93
Biochemical studies on bovine adenovirus type 3. II. Incomplete virus. J Virol (1975) 0.93
Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein. J Virol (2007) 0.92
Comparison of the interactions of the adenovirus type 2 major core protein and its precursor with DNA. Nucleic Acids Res (1986) 0.87
Electron microscopy of cells infected with adenovirus type 2. J Virol (1969) 0.87
Molecular weight of Adenovirus type 2 hexon polypeptide. J Virol (1970) 0.87
Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults. Hum Vaccin Immunother (2013) 0.86
Microtubule-mediated and microtubule-independent transport of adenovirus type 5 in HEK293 cells. J Virol (2007) 0.85
Adenovirus virion stability and the viral genome: size matters. Mol Ther (2009) 0.84
Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem J (1994) 0.82
Accurate single-day titration of adenovirus vectors based on equivalence of protein VII nuclear dots and infectious particles. J Virol Methods (2009) 0.81
Antibody responses against xenotropic murine leukemia virus-related virus envelope in a murine model. PLoS One (2011) 0.80
Disruption of adenovirus type 7 by lithium iodide resulting in the release of viral deoxyribonucleic acid. J Virol (1970) 0.79
The adenovirus genome contributes to the structural stability of the virion. Viruses (2014) 0.79
Viral epigenetics. Methods Mol Biol (2015) 0.78
Lac-regulated system for generating adenovirus 5 vaccine vectors expressing cytolytic human immunodeficiency virus 1 genes. J Virol Methods (2009) 0.77
cid-soluble materialof adenovirus. J Virol (1970) 0.75
Improved method for virus structural polypeptide analysis on dissociating acylamide gel. Appl Microbiol (1971) 0.75
Enhanced graphic matrix analysis of nucleic acid and protein sequences. Proc Natl Acad Sci U S A (1981) 46.11
Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun (1967) 32.60
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
Evidence for virus-specific noncapsid proteins in poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A (1965) 11.84
Acrylamide-gel electrophorograms by mechanical fractionation: radioactive adenovirus proteins. Science (1966) 9.59
Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell (1980) 8.77
Evidence for large precursor proteins in poliovirus synthesis. Proc Natl Acad Sci U S A (1968) 8.24
The evolution and sequence comparison of two recently diverged mouse chromosomal beta--globin genes. Cell (1979) 8.11
The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology (1968) 7.42
The nucleotide sequence of a 5.5-kilobase DNA segment containing the mouse kappa immunoglobulin J and C region genes. J Biol Chem (1981) 7.26
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65
Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science (1980) 5.30
Synthesis, assembly, and secretion of gamma globulin by mouse myeloma cells. I. Adaptation of the Merwin plasma cell tumor-11 to culture, cloning, and characterization of gamma globulin subunits. J Exp Med (1970) 4.26
Rapidly labeled, polyribosome-associated RNA having the properties of histone messenger. Proc Natl Acad Sci U S A (1967) 4.12
Intervening sequence of DNA identified in the structural portion of a mouse beta-globin gene. Proc Natl Acad Sci U S A (1978) 4.02
Rate of somatic mutation in immunoglobulin production by mouse myeloma cells. Proc Natl Acad Sci U S A (1971) 3.83
Preparation of mammalian polyribosomes with the detergent Nonidet P-40. Biochim Biophys Acta (1967) 3.81
Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies. Hybridoma (1981) 3.58
Polyribosomal synthesis and assembly of the H and L chains of gamma globulin. Proc Natl Acad Sci U S A (1966) 3.53
Evolution of human immunoglobulin kappa J region genes. J Biol Chem (1982) 3.41
The decrease in size and synthetic activity of poliovirus polysomes late in the infectious cycle. Virology (1967) 3.41
Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci U S A (1984) 3.35
T7-directed protein synthesis. Virology (1969) 3.32
Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses. Virology (1988) 3.30
Synthesis and structure of Caulobacter crescentus flagella. J Bacteriol (1973) 3.28
Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun (1992) 3.21
Somatic cell hybridization of mouse myeloma cells. Cell (1976) 3.17
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev (1989) 3.09
Structural proteins of adenovirus-associated viruses. J Virol (1971) 3.03
Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis (1992) 2.98
Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J Immunol Methods (1992) 2.97
Determination of the gene sequence of poliovirus with pactamycin. Proc Natl Acad Sci U S A (1971) 2.80
Isolation of a viral polypeptide associated with poliovirus RNA polymerase. Proc Natl Acad Sci U S A (1974) 2.79
Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother (1998) 2.74
Cloning of mouse myeloma cells and detection of rare variants. J Cell Physiol (1972) 2.63
Molecular substructure of a viral receptor-recognition protein. The gp17 tail-fiber of bacteriophage T7. J Mol Biol (1988) 2.59
Studies of the mechanism of enhancement of human adenovirus infection in monkey cells by simian virus 40. J Virol (1972) 2.55
The role of somatic hypermutation in the generation of antibody diversity. Science (1989) 2.55
In vitro assembly of poliovirus-related particles. Virology (1968) 2.55
The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J Immunol (1978) 2.38
Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion. Virology (1969) 2.27
Soluble RNA polymerase complex from poliovirus-infected HeLa cells. Virology (1970) 2.26
Evidence for differences in size and composition of the poliovirus-specific polypeptides in infected HeLa cells. Virology (1968) 2.23
The polypeptides of adenovirus. V. Young virions, structural intermediate between top components and aged virions. Virology (1974) 2.15
The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med (1991) 2.11
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med (1995) 2.11
Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med (1993) 2.09
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol (1992) 2.06
Inhibition of cleavage of large poliovirus-specific precursor proteins in infected HeLa cells by inhibitors of proteolytic enzymes. J Virol (1972) 2.06
A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res (1997) 2.05
Antigen-binding mutants of mouse myeloma cells. Proc Natl Acad Sci U S A (1977) 2.04
The role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol (1992) 2.02
Correlation between splicing sites within an intron and their sequence complementarity with U1 RNA. Cell (1980) 2.02
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother (1994) 2.00
The structural proteins of Newcastle disease virus. Virology (1969) 1.99
The polypeptides of adenovirus. VI. Early and late glycopolypeptides. Virology (1974) 1.98
Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature (1985) 1.95
Mutations in immunoglobulin-producing mouse myeloma cells. Science (1973) 1.94
Evidence for ambiguity in the posttranslational cleavage of poliovirus proteins. Virology (1970) 1.93
Molecular weight estimation of polypeptides by SDS-polyacrylamide gel electrophoresis: further data concerning resolving power and general considerations. Anal Biochem (1969) 1.92
A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res (1990) 1.90
Variants of a mouse myeloma cell line that synthesize immunoglobulin heavy chains having an altered serotype. Proc Natl Acad Sci U S A (1975) 1.87
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc Natl Acad Sci U S A (1989) 1.87
A program for predicting significant RNA secondary structures. Comput Appl Biosci (1988) 1.87
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc Natl Acad Sci U S A (1993) 1.86
Return to the past: the case for antibody-based therapies in infectious diseases. Clin Infect Dis (1995) 1.86
Fc receptors induced by herpes simplex virus. I. Biologic and biochemical properties. J Immunol (1978) 1.85
In vitro protein synthetic activity of membrane-bound poliovirus polyribosomes. Virology (1971) 1.84
Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J Exp Med (2000) 1.82
Immunoglobulin production: method for quantitatively detecting variant myeloma cells. Science (1970) 1.81
HIV-1 reverse transcriptase: structure predictions for the polymerase domain. AIDS Res Hum Retroviruses (1990) 1.80
The polypeptides of adenovirus. IV. Detection of early and late virus-induced polypeptides and their distribution in subcellular fractions. Virology (1974) 1.80
Lymphoblastoid cell lines from patients with chronic lymphocytic leukemia: identification of tumor origin by idiotypic analysis. Proc Natl Acad Sci U S A (1978) 1.78
The polypeptides of adenovirus. 3. Synthesis in infected cells. Virology (1969) 1.77
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc Natl Acad Sci U S A (1997) 1.72
Synthesis of ribosomal RNA in synchronized HeLa cells. Nature (1965) 1.69
Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol (1995) 1.67
Synthesis of excess light chains of gamma globulin by rabbit lymph node cells. Nature (1966) 1.66
Variants of mouse myeloma cells that produce short immunoglobulin heavy chains. Proc Natl Acad Sci U S A (1974) 1.66
Novel GACG-hairpin pair motif in the 5' untranslated region of type C retroviruses related to murine leukemia virus. J Virol (1992) 1.64
Polyribosome disaggregation during metaphase. Science (1966) 1.61
Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61
Effect of adenovirus on host cell DNA synthesis in synchronized cells. Virology (1969) 1.61
Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci U S A (1997) 1.61
Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. J Exp Med (1997) 1.60
Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell (1981) 1.60
Tree graphs of RNA secondary structures and their comparisons. Comput Biomed Res (1989) 1.59
Mapping of adenovirus messenger RNA by electron microscopy. Proc Natl Acad Sci U S A (1976) 1.56
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55